Kerin B Adelson
Overview
Explore the profile of Kerin B Adelson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
529
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Canavan M, Westvold S, Csik V, Franks J, Rocque G, Gross C, et al.
J Natl Cancer Inst
. 2025 Jan;
PMID: 39842859
It has long been assumed that academic oncology practices are disadvantaged in value-based payment programs, due to patient complexity and research costs. This assumption not been tested. The Oncology Care...
2.
Shimer S, Allen O, Yang C, Canavan M, Westvold S, Kim N, et al.
J Palliat Med
. 2024 Jul;
27(7):879-887.
PMID: 38990245
Prior studies reveal a lack of illness understanding and prognostic awareness among patients with hematological malignancies. We evaluated prognostic awareness and illness understanding among patients with acute leukemia and multiple...
3.
Canavan M, Wang X, Ascha M, Miksad R, Showalter T, Calip G, et al.
JAMA Oncol
. 2024 May;
10(7):887-895.
PMID: 38753341
Importance: Two prominent organizations, the American Society of Clinical Oncology and the National Quality Forum (NQF), have developed a cancer quality metric aimed at reducing systemic anticancer therapy administration at...
4.
Prsic E, Morris J, Adelson K, Parker N, Gombos E, Kottarathara M, et al.
Cancer
. 2023 Sep;
129(23):3797-3804.
PMID: 37706601
Background: Unplanned hospitalizations among patients with advanced cancer are often sentinel events prompting goals of care discussions and hospice transitions. Late referrals to hospice, especially those at the end of...
5.
Morris J, Gould Rothberg B, Prsic E, Parker N, Weber U, Gombos E, et al.
J Hosp Med
. 2023 Mar;
18(5):391-397.
PMID: 36891947
Background: Smilow Cancer Hospital (SCH) introduced hospitalist comanagement to the inpatient oncology service to address long lengths of stay and oncologist burnout. Objective: To determine the impact of hospitalists on...
6.
Canavan M, Wang X, Ascha M, Miksad R, Calip G, Gross C, et al.
JAMA Oncol
. 2022 Oct;
8(12):1847-1849.
PMID: 36264566
No abstract available.
7.
Yardley D, Young R, Adelson K, Silber A, Najera J, Daniel D, et al.
Clin Breast Cancer
. 2021 Nov;
22(3):269-278.
PMID: 34824002
Background: AR is a targetable pathway with AR modulation inhibiting estrogen- and androgen-mediated cell proliferation. Orteronel is an oral, selective, nonsteroidal inhibitor of 17, 20-lyase, a key enzyme in androgen...
8.
Gould Rothberg B, Canavan M, Mun S, Sedghi T, Carafeno T, Raucci M, et al.
JCO Oncol Pract
. 2021 Aug;
18(1):e129-e136.
PMID: 34383579
Purpose: Acute care imposes a significant burden on patients and cancer care costs. We examined whether an advanced practice provider-driven, cancer-specific urgent care center embedded within a large tertiary academic...
9.
Pintova S, Leibrandt R, Smith C, Adelson K, Gonsky J, Egorova N, et al.
JCO Oncol Pract
. 2020 Aug;
16(12):e1499-e1506.
PMID: 32749930
Purpose: To describe the length of encounter during visits where goals-of-care (GoC) discussions were expected to take place. Methods: Oncologists from community, academic, municipal, and rural hospitals were randomly assigned...
10.
Riaz F, Gan G, Li F, Davidoff A, Adelson K, Presley C, et al.
JCO Oncol Pract
. 2020 Jul;
16(11):e1355-e1370.
PMID: 32678688
Purpose: As immune checkpoint inhibitors (ICIs) have transformed the care of patients with cancer, it is unclear whether treatment at the end of life (EOL) has changed. Because aggressive therapy...